| scholarly article | Q13442814 |
| P50 | author | Age-Related Eye Disease Study Research Group | Q83234373 |
| P2860 | cites work | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9 | Q24546140 | ||
| The effect of zinc supplements on plasma zinc and copper levels and the reported symptoms in healthy volunteers | Q28300419 | ||
| Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91 | Q28372839 | ||
| The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. | Q34655539 | ||
| Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India | Q39482109 | ||
| Zinc metabolism and surgical trauma | Q44622357 | ||
| Zinc-induced copper deficiency: megamineral sideroblastic anemia. | Q49213068 | ||
| [The relationship between zinc, copper and lipid metabolic indicators in adults]. | Q50909888 | ||
| Serum zinc and serum lipid profiles in 778 adults. | Q51584746 | ||
| Evidence of functional zinc deficiency in Parkinson's disease | Q64864326 | ||
| Zinc supplements and serum lipids in young adult white males | Q67921365 | ||
| Oral zinc in macular degeneration | Q68126625 | ||
| Influence of acute tissue injury on zinc metabolism in man | Q70453478 | ||
| Excessive intake of zinc impairs immune responses | Q70593711 | ||
| Effect of zinc supplementation on copper status in adult man | Q70635967 | ||
| Zinc distribution in blood components, inflammatory status, and clinical indexes of disease activity during zinc supplementation in inflammatory rheumatic diseases | Q70676903 | ||
| Zinc lowers high-density lipoprotein-cholesterol levels | Q71335391 | ||
| Serum calcium, magnesium, copper and zinc and risk of cardiovascular death | Q71665255 | ||
| Concentrations of calcium, magnesium, zinc and copper in relation to free fatty acids and cholesterol in serum of atherosclerotic men | Q72358613 | ||
| [Antioxidants and angiogenetic factor associated with age-related macular degeneration (exudative type)] | Q73189517 | ||
| Metallothionein, zinc and copper levels: relationship with acute myocardial infarction | Q73377561 | ||
| Copper/zinc ratio and systemic oxidant load: effect of aging and aging-related degenerative diseases | Q77507800 | ||
| Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1 beta and tumour necrosis factor alpha | Q77521991 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 697-702 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Journal of Nutrition | Q3186931 |
| P1476 | title | The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7. | |
| P478 | volume | 132 |
| Q45935436 | A 12-week lutein supplementation improves visual function in Chinese people with long-term computer display light exposure. |
| Q42565175 | Advances in technology helps in early detection of vision disorders |
| Q79806687 | Age- and sex-dependent effects of long-term zinc supplementation on essential trace element status and lipid metabolism in European subjects: the Zenith Study |
| Q37315838 | Aging is not a disease: distinguishing age-related macular degeneration from aging |
| Q24201127 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q24242944 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q38631993 | Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges |
| Q44781025 | Determinants of serum zinc concentrations in a population of French middle-age subjects (SU.VI.MAX cohort). |
| Q28769548 | Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration |
| Q26798492 | Effects of Zinc supplementation on serum lipids: a systematic review and meta-analysis |
| Q35031681 | Serum zinc concentrations correlate with mental and physical status of nursing home residents |
| Q89454097 | Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes |
| Q37030323 | The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples |
| Q37489484 | The impact of fish and shellfish consumption on age-related macular degeneration |
| Q37223032 | Transcutaneous electrical retinal stimulation therapy for age-related macular degeneration |
| Q34976109 | Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degeneration. |
| Q81412135 | Zinc intake and status in middle-aged and older European subjects: the ZENITH study |
Search more.